JPRN-UMIN000024623Completed未知
Examining immune-related molecules for the discovery of potential therapeutic targets in non-small cell lung cancers through the analysis of fresh peripheral blood and/or pleural effusion from patients treated with anti-PD-1 antibodies. - Immune-profiling of fresh peripheral blood and/or pleural effusion from non-small cell lung cancer patients treated with anti-PD-1 antibodies.
Osaka University Graduate School of Medicine0 sites100 target enrollmentStarted: October 31, 2016Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
Prospective immune-profiling using fresh whole blood still on going. In follow-up study after discontinuation of anti-PD-1 treatment, we monitored anti PD-1 antibody binding and immune profiling in T cells until complete loss of residual therapeutic antibody binding. We reported the partial results at IASLC meeting 2017(https://www.sciencedirect.com/science/article/pii/S1556086417329428). We completed the recruitment for the follow-up study May 2017.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)With interstitial pneumonia or pulmonary fibrosis on a chest X-ray 2)Clinically significant drug allergy 3)Presence of other active malignancy 4)With pericardial effusion, pleural effusion and ascites in need of treatment of drainage 5)Positive serum HBs antigen 6)With severe infection, cardiac diseases, diabetes, hypertension, other severe complication 7)Patients received palliative radiotherapy for brain metastases and bone metastases, except for the primary lesion within 2weeks. 8)Pregnancy or lactating patients
Investigators
Similar Trials
Recruiting
Not Applicable
Immune Reconstitution in Stem Cell Transplant RecipientsCancerNCT02129543University of Miami700
Completed
Not Applicable
Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's BiopsiesPolymyalgia RheumaticaNCT04727879University Hospital, Brest20
Completed
Not Applicable
Project REMOTE (REimagining Measurements and Operations of Translational Endpoints)COVID-19NCT06776367Biomedical Advanced Research and Development Authority1,753
Recruiting
Not Applicable
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchMalignant Solid TumorsPrimary Brain TumorSoft Tissue SarcomaKidney CancerColorectal CancerMelanomaProstate CancerNCT05539677N.N. Petrov National Medical Research Center of Oncology1,000
Withdrawn
Not Applicable
Gene Polymorphism Study of Normal Individual Inflammasome GenesHealthy IndividualsNCT01988805Ohio State University